Capital Fund Management S.A. Neurocrine Biosciences Inc Put Options Transaction History

Capital Fund Management S.A.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 13, 2019	SELL	$68.32 - $124.36 $1.43 Million - $2.6 Million	-20,900 Reduced 53.59%	18,100 $1.29 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $3.86 Million - $4.91 Million	39,000 New	39,000 $4.8 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $5.89 Million - $8.29 Million	-78,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $5.93 Million - $7.23 Million	78,200 New	78,200 $6.49 Million

642

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.